TrAC Trends in Analytical Chemistry, Journal Year: 2024, Volume and Issue: 181, P. 118037 - 118037
Published: Nov. 7, 2024
Language: Английский
TrAC Trends in Analytical Chemistry, Journal Year: 2024, Volume and Issue: 181, P. 118037 - 118037
Published: Nov. 7, 2024
Language: Английский
Neurosurgical Review, Journal Year: 2025, Volume and Issue: 48(1)
Published: Feb. 28, 2025
Polyuria, or excessive fluid loss through the kidneys, is a common issue in neurocritical patients, often resulting from conditions such as volume overload, osmotic diuretics, central diabetes insipidus (CDI), cerebral salt wasting syndrome (CSWS). Notably, specific cause of postoperative polyuria within 24 h patients with tumors located supratentorial non-midline region remains poorly understood. To address this gap, we conducted prospective observational study 30 and found that eight (26.7%) experienced polyuria. Binary logistic regression analysis clinical data ruled out diuretics underlying causes polyuria, suggested very subtle association between tumor size (OR = 1.030; p 0.041). A significant decrease serum sodium levels group (p 0.005) pointed towards CSWS potential mechanism. Differentiating CDI CSWS, both involving neuroendocrine hormone dysregulation, challenging due to lack efficient tests. overcome this, developed novel liquid chromatography-tandem mass spectrometry (LC-MS)-based targeted quantitative method measure seven hormones, including antidiuretic (ADH) related six natriuretic peptides associated CSWS. Elevated atrial peptide (ANP), brain (BNP), C-type (CNP), ADH were observed group. Univariate identified ANP, BNP, significantly at threshold < 0.1. Later, multivariate further revealed elevated BNP an independent risk factor for 9111.901; 0.022). These findings suggest may be primary tumors, evidenced by concomitant increase peptides, particularly BNP.
Language: Английский
Citations
0BioTechniques, Journal Year: 2025, Volume and Issue: unknown, P. 1 - 4
Published: Jan. 31, 2025
Keywords: GenomicsNeurodegenerative diseasesMulti-omicsProteomicstranscriptomicsAlzheimer'sParkinson's
Language: Английский
Citations
0Elsevier eBooks, Journal Year: 2025, Volume and Issue: unknown
Published: Jan. 1, 2025
Language: Английский
Citations
0Journal of Proteome Research, Journal Year: 2024, Volume and Issue: unknown
Published: Oct. 22, 2024
Recent advancements in single-cell (sc) resolution analyses, particularly sc transcriptomics and proteomics, have revolutionized our ability to probe understand cellular heterogeneity. The study of metabolism through small molecules, metabolomics, provides an additional level information otherwise unattainable by or proteomics shedding light on the metabolic pathways that translate gene expression into functional outcomes. Metabolic heterogeneity, critical health disease, impacts developmental outcomes, disease progression, treatment responses. However, dedicated approaches probing metabolome not reached maturity other omics technologies. Over past decade, innovations metabolomics addressed some practical limitations, including cell isolation, signal sensitivity, throughput. To fully exploit their potential biological research, however, remaining challenges must be thoroughly addressed. Additionally, integrating with orthogonal techniques will required validate relevant results gain systems-level understanding. This perspective offers a broad-stroke overview recent mass spectrometry (MS)-based advancements, focusing ongoing from biologist's viewpoint, aimed at addressing pertinent innovative questions. we emphasize use showcase systems these sophisticated methodologies are apt explore.
Language: Английский
Citations
3Journal of Chromatography A, Journal Year: 2024, Volume and Issue: 1736, P. 465406 - 465406
Published: Sept. 30, 2024
Language: Английский
Citations
0TrAC Trends in Analytical Chemistry, Journal Year: 2024, Volume and Issue: 181, P. 118037 - 118037
Published: Nov. 7, 2024
Language: Английский
Citations
0